Clinical studies have always been an irreplaceable part of the medical innovation process, and it is no different here at Silence Therapeutics. We use clinical studies to evaluate our investigational short interfering RNA (siRNA) therapies as effective, durable, and safe treatment options for both common and rare genetic diseases.
Silence Therapeutics holds our clinical studies to the highest standards of safety and ethics. We continue to monitor the COVID-19 pandemic and post-pandemic affects with participant safety in mind.
Learn more about our ongoing clinical studies and opportunities for participants and investigators below.